Skip to main content

Table 2 Prevalence of VRSA in S. aureus and VRSA in MRSA based on year published

From: RETRACTED ARTICLE: Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates

Subject

Sub group

No. studies

No. strains

Proportion (95% CI)

%Weight

P

I2

P sig

2015–2020

VRSA

31

5798

0.07 (0.04, 0.11)

54.71

0

0.9579

0

VRSA from MRSA

16

1608

0.06 (0.03, 0.10)

61.54

0

0.8246

0

2006–2014

VRSA

28

6692

0.06 (0.03, 0.09)

39.35

0

0.9620

0

VRSA from MRSA

9

4408

0.05 (0.00, 0.14)

28.22

0

0.9771

0.01

 < 2006

VRSA

4

466

0.02 (0, 0.04)

5.93

0.17

0.3949

0.01

VRSA from MRSA

3

327

0.01 (0, 0.05)

10.24

–

–

0.15

  1. I2: the percentage of variance in a meta-analysis that shows study heterogeneity. VRSA Vancomycin-resistant Staphylococcus aureus, MRSA Methicillin-resistant Staphylococcus aureus
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us